The outlook of companies tied to Viagra's past presents a intricate investment picture . While the initial surge generated substantial gains, generic alternatives have significantly impacted sales . Investing in related pharmaceutical firms now requires a thorough assessment of patent protection , evolving healthcare shifts , and the prospect for b